Sort
172,184 grants matching “inflammation”
Women's Health Study: Continued Follow-Up
$875,149Julie E Buring · Brigham And Women'S Hospital · R01 · FY2008 · HL
Infections, immunity, and inflammation in cancer
$875,117Eric A Engels · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Osteoporotic Fractures in Men (MrOS) - Minneapolis
$875,110Kristine Ensrud · University Of Minnesota · U01 · FY2016 · AG
Next generation MEMS-VCSEL technology for ultra-low-cost dental and periodontal swept source optical coherence tomography imaging
$875,000Vijaysekhar Jayaraman · Praevium Research, Inc. · R44 · FY2023 · DE
Innovative therapeutic approaches to treat chronic kidney disease
$875,000Andrew S. Terker · Vanderbilt University Medical Center · DP5 · FY2025 · OD
Personalized oxygen therapy for critically ill adults: a randomized trial
$874,997Matthew Wall Semler · Vanderbilt University Medical Center · R61 · FY2025 · HL
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
$874,967Mark Scott Sundrud · Scripps Florida · R01 · FY2021 · AI
Proteomic Markers of Arteriosclerosis
$874,844Iftikhar J Kullo · Mayo Clinic Rochester · U01 · FY2008 · HL
Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data
$874,792Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2024 · HL
Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention.
$874,747Andrew T Chan · Massachusetts General Hospital · R01 · FY2024 · CA
Sphingosine Kinase Inhibitors as Anti-IBD Agents
$874,563Lynn W Maines · Apogee Biotechnology Corporation · R44 · FY2007 · DK
Targeting the Endothelium in Sepsis
$874,540Robert C Flaumenhaft · Beth Israel Deaconess Medical Center · R01 · FY2014 · HL
Effects of Oral Inflammation on the Levels of Salivary Biomarkers of AMI
$874,517John T McDevitt · Rice University · U01 · FY2010 · DE
Core C1: Data Interpretation Core
$874,506Ronald Gary Tompkins · Massachusetts General Hospital · U54 · FY2010 · GM
Development of heparan sulfate-based therapeutics to treat inflammatory diseases
$874,308Zhangjie Wang · Glycan Therapeutics Corporation · R44 · FY2023 · GM
Basic Research Support for the CCR
$874,282Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Cellular Decision Making
$874,280Orion D Weiner · University Of California, San Francisco · R35 · FY2020 · GM
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
$874,216Marilyn L Kwan · Kaiser Foundation Research Institute · U01 · FY2025 · CA
Cellular Decision Making
$874,159Orion D Weiner · University Of California, San Francisco · R35 · FY2019 · GM
AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline
$874,146Edward R Marcantonio · Beth Israel Deaconess Medical Center · R01 · FY2023 · AG
Phase II studies of gamma tocopherol as an intervention for environmental asthma
$874,100David B Peden · Univ Of North Carolina Chapel Hill · R01 · FY2017 · ES
Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH
$873,988Suman Srinivasa · Massachusetts General Hospital · R01 · FY2020 · HL
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$873,986Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2011 · HL
Pharmacology and drug development core
$873,965Diane Heck · Rbhs-Robert Wood Johnson Medical School · U54 · FY2013 · AR
Abdominal Symptom Phenotypes: Pathways to New Biomarkers
$873,879Margaret McLean Heitkemper · University Of Washington · RC2 · FY2010 · NR